Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Rabea Asleh"'
Autor:
Senthil Anand, Hilmi Alnsasra, Lisa M. LeMond, Sanskriti Shrivastava, Rabea Asleh, Andrew Rosenbaum, Semaan Kobrossi, Akanksha Mohananey, Katie Murphy, Byron H. Smith, Sudhir Kushwaha, David E. Steidley, Alfredo Clavell, Phillip Young, Naveen L. Pereira
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1594-1601 (2024)
Abstract Aims Graft dysfunction (GD) after heart transplantation (HTx) can develop without evidence of cell‐ or antibody‐mediated rejection. Cardiac magnetic resonance imaging (CMR) has an evolving role in detecting rejection; however, its role i
Externí odkaz:
https://doaj.org/article/71ea1ac8c4454a00b303cf12bc656b78
Autor:
Dean Nachman, Arik Eisenkraft, Yotam Kolben, Erez Carmon, Esther Hazan, Nir Goldstein, Arik Ben Ishay, Mor Hershkovitz, Meir Fons, Roei Merin, Offer Amir, Rabea Asleh, Yftach Gepner
Publikováno v:
Digital Health, Vol 9 (2023)
Background Recent technological developments enable big data-driven insights on diurnal changes. This study aimed to describe the trajectory of multiple and advanced parameters using a medical-grade wearable remote patient monitor. Methods Parameters
Externí odkaz:
https://doaj.org/article/6483d7d0551c44bb8282bfad6676f9f2
Autor:
Marco Gemelli, Ilias P. Doulamis, Aspasia Tzani, Athanasios Rempakos, Polydoros Kampaktsis, Paulino Alvarez, Alvise Guariento, Andrew Xanthopoulos, Grigorios Giamouzis, Kyriakos Spiliopoulos, Rabea Asleh, Ernesto Ruiz Duque, Alexandros Briasoulis
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 1, p 52 (2023)
(1) Background: Heart failure is an extremely impactful health issue from both a social and quality-of-life point of view and the rate of patients with this condition is destined to rise in the next few years. Transplantation remains the mainstay of
Externí odkaz:
https://doaj.org/article/d371aeba4b57486f82cea8dad3749773
Autor:
Ram Gelman, Noa Hurvitz, Rima Nesserat, Yotam Kolben, Dean Nachman, Khurram Jamil, Samuel Agus, Rabea Asleh, Offer Amir, Marc Berg, Yaron Ilan
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 161, Iss , Pp 114334- (2023)
Introduction: Diuretics are a mainstay therapy for congestive heart failure (CHF); however, over one-third of patients develop diuretic resistance. Second-generation artificial intelligence (AI) systems introduce variability into treatment regimens t
Externí odkaz:
https://doaj.org/article/983a8cfae8e1448cbbb95558d20bf79d
Autor:
Rabea Asleh, Alexandros Briasoulis, Ilias Doulamis, Hilmi Alnsasra, Aspasia Tzani, Paulino Alvarez, Toshiki Kuno, Polydoros Kampaktsis, Sudhir Kushwaha
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 1167-1174 (2022)
Abstract Background The number of patients with sarcoidosis requiring heart transplantation (HT) is increasing. The aim of this study was to evaluate outcomes of isolated HT in patients with sarcoid cardiomyopathy and compare them to recipients with
Externí odkaz:
https://doaj.org/article/60a3d49fee494cf283d49c9c7cbb130c
Autor:
Tal Gazitt, Fadi Kharouf, Joy Feld, Amir Haddad, Nizar Hijazi, Adi Kibari, Alexander Fuks, Edmond Sabo, Maya Mor, Hagit Peleg, Rabea Asleh, Devy Zisman
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 16, p 5278 (2023)
Despite the increasing recognition of cardiac involvement in systemic sarcoidosis, the diagnosis of cardiac sarcoidosis (CS) remains challenging. Our aim is to present a comprehensive, retrospective case series of CS patients, focusing on the current
Externí odkaz:
https://doaj.org/article/bfb82ed7b8034f168d89fd2ec7daaaa9
Autor:
Polydoros N. Kampaktsis, Ilias P. Doulamis, Rabea Asleh, Elpiniki Makri, Ilias Kalamaras, Christoforos Papastergiopoulos, Maria Emfietzoglou, Anastasis Drosou, Jef Van den Eynde, Hilmi Alnsasra, Ernesto Ruiz Duque, Alexandros Briasoulis
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 17 (2022)
Background The clinical characteristics of mTOR (mammalian target of rapamycin) inhibitors use in heart transplant recipients and their outcomes have not been well described. Methods and Results We compared patients who received mTOR inhibitors withi
Externí odkaz:
https://doaj.org/article/b5ead02d726c4252b84076283c6003a1
Autor:
Polydoros N. Kampaktsis, Serafeim Moustakidis, Aspasia Tzani, Ilias P. Doulamis, Anastasios Drosou, Andreas Tzoumas, Rabea Asleh, Alexandros Briasoulis
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 3433-3436 (2021)
Externí odkaz:
https://doaj.org/article/58be8a656cec4004bf57d3b0620b6c43
Autor:
Fouad Khalil, Rabea Asleh, Radha Kanneganti Perue, Jean-Marc Weinstein, Adam Solomon, Batya Betesh-Abay, Alexandros Briasoulis, Hilmi Alnsasra
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 757 (2023)
Left ventricular assist devices (LVADs) have been increasingly used in patients with advanced heart failure, either as a destination therapy or as a bridge to heart transplant. Continuous flow (CF) LVADs have revolutionized advanced heart failure tre
Externí odkaz:
https://doaj.org/article/169955e829aa48f7b3fc04b26408b536
Autor:
Maya Dagan, Yotam Kolben, Nir Goldstein, Arik Ben Ishay, Meir Fons, Roei Merin, Arik Eisenkraft, Offer Amir, Rabea Asleh, Arie Ben-Yehuda, Dean Nachman
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 1, p 45 (2022)
There are no clear guidelines for diuretic administration in heart failure (HF), and reliable markers are needed to tailor treatment. Continuous monitoring of multiple advanced physiological parameters during diuresis may allow better differentiation
Externí odkaz:
https://doaj.org/article/dea828a7f18e4b27808437fca38f078e